Florida / New York

A Publication for the Practicing Medical Specialist, Industry Executive & Investor

INDUSTRY EXPERT ARTICLES

Medical Device News Magazine publishes feature articles from industry experts on medical device technology, regulation, reimbursement, and business strategy.

Hemorrhagic Stroke

The Journey to Establishing the World’s First Successful Surgical Treatment for Hemorrhagic Stroke | By Jim Pearson, President & CEO, NICO Corporation

Jim Pearson advises October 29th is World Stroke Day (WSD) — an important day for the global stroke community to take action, educate, and focus on prevention. It is also a chance to deeply reflect on how we can continue to serve people who will suffer strokes in the future. For us leaders in the life sciences, WSD is a powerful reminder to ask ourselves how we can continue to innovate in order to decrease the lives lost and improve both clinical and economic outcomes. Over the past decade, we have built a company and team at NICO Corporation dedicated to bringing forth new innovations and, more importantly, scientific evidence in the deadliest type of stroke — hemorrhagic stroke. Read to learn more.

Read More
Christine Cooper, CEO of aequum LLC

A Strategic, Compliant Response to No Surprise Act Supported by Medical Billing Partnership | By Christine Cooper, CEO of aequum LLC

More than a year ago, the U.S. healthcare system marked a turning point with the passage of the No Surprises Act (NSA). Signed into federal law after extensive negotiation between health plan insurers and providers, the NSA took full effect at the start of 2022 to protect the rights of patients and health plan participants from receiving excessive balance bills for certain emergency services and from out-of-network providers at in-network facilities.

Read More
Patient-Reported Outcomes

The Evolution of Mixed-Modes Patient-Reported Outcomes Guidance: A Journey Towards Evidence-Based Practices in BYOD | By: Dr. Jill Platko, Vice President of Scientific Services at Suvoda

Collecting patient-reported outcome (PRO) data is an integral function of clinical research, providing the patient perspective that enriches the evaluation of treatment effectiveness. Historically, patient-reported outcomes measurement (PROM) was performed predominantly with paper-based assessments. However, over the past two decades, there has been a notable paradigm shift towards the electronic collection of data.

Read More
Cryoablation Therapy for Breast Cancer

Cryoablation Therapy for Breast Cancer (and other cancers) | By Dr. John Oertle, Chief Medical Director at Envita Medical Centers

Cancer care continues to be one of the key cost drivers contributing to the $3.5 trillion healthcare costs in the United States, but minimally invasive treatments like Cryoablation Therapy may hold the promise of significantly reducing oncology related costs, while improving patient outcomes. It has the potential of reducing months of recovery time to only a few minutes, and the scope of cryoablation expands exponentially especially when utilized in concert with personalized precision medicine. Read on.

Read More